Financial Performance - The company's net revenues for 2Q25 reached $14.58 billion[3], while year-to-date (YTD) net revenues amounted to $29.65 billion[3] - Net earnings for 2Q25 were $3.72 billion[3], and YTD net earnings totaled $8.46 billion[3] - Diluted earnings per share (EPS) for 2Q25 stood at $10.91[3], with a YTD EPS of $25.07[3] - The annualized return on equity (ROE) for 2Q25 was 12.8%[3], and the YTD ROE was 14.8%[3] - The annualized return on tangible equity (ROTE) for 2Q25 was 13.6%[3], with a YTD ROTE of 15.8%[3] Segment Performance - Global Banking & Markets reported net revenues of $10.12 billion for 2Q25, a 24% increase compared to 2Q24[6] - Asset & Wealth Management's net revenues for 2Q25 were $3.778 billion, a 3% decrease compared to 2Q24[6] - Platform Solutions generated net revenues of $685 million for 2Q25, a 2% increase compared to 2Q24[6] Asset & Wealth Management - Assets Under Supervision (AUS) - Total assets under supervision (AUS) reached a record $3.29 trillion[3] - Long-term AUS net inflows were $17 billion[28] - Liquidity products experienced net outflows of $12 billion[28]

Financial Performance - Net income available to common shareholders (NIAC) increased to $233 million, a 27% increase compared to 2Q24[7] - Diluted EPS increased to $045, a 32% increase compared to 2Q24[7] - Adjusted ROTCE was 136%, an increase of 57bps from 1Q25[12] - Adjusted PPNR was $338 million, up 1% from 1Q25[14] Balance Sheet - Period end loans increased by $1 billion from 1Q25, driven by loans to mortgage companies (LMC) seasonality and continuing growth within C&I[10] - Period end deposits increased by $14 billion from 1Q25, reflecting incremental brokered deposits and DDA growth[10] - The loan-to-deposit ratio was 96%, down slightly from 1Q25[10] - Tangible book value per share (TBVPS) increased by $040 to $1357, driven by strong earnings & mark-to-market impact[10] Asset Quality & Capital - CET1 ratio was maintained at 110%, in line with the near-term target[10] - ACL/loans ratio decreased by 3bps to 142%, reflecting loans to mortgage companies (LMC) growth and upgrades[10]

Financial Outlook Update - The company raises its net sales outlook to $31.6 - $31.8 billion[27], representing an increase of 4.3% compared to Fiscal Year 2024 on a 52-week basis[27] - The company anticipates adjusted EBITDA of $535 - $565 million[27], reflecting an increase of 4.3% compared to Fiscal Year 2024 on a 52-week basis[27] - The company projects free cash flow of approximately $200 million[27], a roughly 4.3-times increase compared to Fiscal Year 2024[27] - The company estimates capital and cloud implementation expenditures of around $250 million[27], a decrease of approximately $120 million compared to Fiscal Year 2024[27] Cyber Incident Impact - The company estimates lost sales due to the cyber incident to be approximately $(350)-$(400) million[31] - The company estimates the cyber incident will impact adjusted EBITDA by approximately $(40)-$(50) million[31] - The company estimates a pre-tax and free cash flow loss of approximately $(65)-$(75) million due to the cyber incident[31] - The company estimates that the cyber incident will impact net (loss) income by $50 to $60 million[34] Strategic Focus - The company is focused on supporting customers and suppliers through solutions-oriented teamwork and transparent communication[22] - The company's strong cyber security protocol helped protect UNFI and partner personal information[22] - The company is on track to accelerate achievement of multi-year targets vs October 2024 targets[22]

Q2 2025 Financial Performance - Worldwide sales reached $23.7 billion, a 5.8% increase compared to Q2 2024, with operational sales growth of 4.6%[47] - U S sales increased by 7.8% to $13.5 billion in Q2 2025 from $12.6 billion in Q2 2024[47] - Adjusted earnings were $6.7 billion, and adjusted EPS was $2.77[49] - GAAP net earnings increased to $5.5 billion, a rise of 18.2%[49] Innovative Medicine - Innovative Medicine sales reached $15.202 billion, with operational growth of 3.8%[51] - Oncology sales grew by 22.3% operationally, reaching $6.312 billion[51] - Immunology sales declined by 16% operationally, totaling $3.993 billion, impacted by STELARA biosimilar competition[51] MedTech - MedTech sales were $8.541 billion, with operational growth of 6.1%[53] - Cardiovascular sales increased by 22.3% operationally, reaching $2.313 billion[53] - Orthopaedics sales decreased by 1.6% operationally, totaling $2.305 billion[53] Guidance - The company increased its operational sales guidance for 2025 to 4.8% and adjusted operational EPS guidance to 7.0% (midpoints)[62] - Operational sales are projected to be between $92.7 billion and $93.1 billion[62]

Consolidated Financial Performance - Net revenues for the second quarter of 2025 were $16792 million, a decrease of 5% from the first quarter of 2025 but an increase of 12% from the second quarter of 2024[2] - Net income applicable to Morgan Stanley for the second quarter of 2025 was $3539 million, a decrease of 18% from the first quarter of 2025 but an increase of 15% from the second quarter of 2024[2] - Earnings applicable to Morgan Stanley common shareholders for the second quarter of 2025 were $3392 million, a decrease of 18% from the first quarter of 2025 but an increase of 15% from the second quarter of 2024[2] - For the six months ended June 30, 2025, net revenues were $34531 million, a 15% increase compared to $30155 million for the six months ended June 30, 2024[2] - For the six months ended June 30, 2025, earnings applicable to Morgan Stanley common shareholders were $7549 million, a 22% increase compared to $6208 million for the six months ended June 30, 2024[2] Segment Performance - Institutional Securities net revenues for the second quarter of 2025 were $7643 million, a decrease of 15% from the first quarter of 2025 but an increase of 9% from the second quarter of 2024[2] - Wealth Management net revenues for the second quarter of 2025 were $7764 million, an increase of 6% from the first quarter of 2025 and a 14% increase from the second quarter of 2024[2] - Investment Management net revenues for the second quarter of 2025 were $1552 million, a decrease of 3% from the first quarter of 2025 but an increase of 12% from the second quarter of 2024[2] Balance Sheet and Capital - Total assets as of June 30, 2025, were $1353870 million, a 4% increase from March 31, 2025, and a 12% increase from June 30, 2024[5] - Total loans as of June 30, 2025, were $267395 million, a 3% increase from March 31, 2025, and a 12% increase from June 30, 2024[5] - Common equity as of June 30, 2025, was $98434 million, a 1% increase from March 31, 2025, and a 7% increase from June 30, 2024[5]

Financial Performance Highlights - Revenue reached $26.5 billion, a 4% year-over-year increase[2] - Net income was $7.1 billion, up 3% year-over-year[2] - Earnings per share (EPS) increased by 7% year-over-year to $0.89[2] - The return on average common shareholders' equity (ROE) was 100% and return on average tangible common shareholders' equity (ROTCE) was 134%[2] Balance Sheet Strength - Deposits totaled $20 trillion, a 5% increase year-over-year[2] - The common equity tier 1 (CET1) ratio was 115%, exceeding regulatory minimums[2] - Global liquidity sources (GLS) averaged $938 billion[2] Business Segment Growth - Consumer investment assets increased by 13% year-over-year to approximately $540 billion[9] - Global Banking average deposits grew 15% year-over-year to over $600 billion[10] - Global Wealth & Investment Management (GWIM) client balances increased 10% year-over-year to $44 trillion, with assets under management (AUM) up 13%[9] Artificial Intelligence and Innovation - The company is leveraging AI to drive efficiencies across various operations, including customer service, content summarization, and code generation[11] - Over 50 AI-enabled fraud detection models are in use[11] - The company has approximately 1,400 AI and machine learning patents granted and pending[11] Net Interest Income and Outlook - Net interest income (NII) increased by 7% year-over-year to $147 billion[14] - The company expects net interest income to be approximately $155 billion-$157 billion in 4Q25[51] Asset Quality - Total net charge-offs were $15 billion[12] - The allowance for loan and lease losses represented 117% of total loans and leases[65]

ASML reports €7.7 billion total net sales and €2.3 billion net income in Q2 2025 Agenda July 16, 2025 Page 2 Public • Investor key messages • Business summary • Outlook • Financial statements Full-year 2025 expected total net sales growth of around 15% with gross margin around 52% ASML 2025 Second-Quarter Veldhoven, the Netherlands July 16, 2025 Investor key messages July 16, 2025 Page 3 Investor key messages July 16, 2025 Page 4 Public • The semiconductor industry remains strong, driven by artificial intel ...

Transaction Overview - Mount Gibson Iron (MGX) is acquiring a 50% interest in the Central Tanami Project JV (CTPJV) from Northern Star Resources Ltd (NST)[10] - The acquisition cost is $50 million, plus adjustments[10] - The transaction is conditional and expected to be completed by March 31, 2026[26] Central Tanami Gold Project (CTPJV) - The CTPJV has a significant Mineral Resource of 1.6 million ounces of gold (100% basis)[10] - The project area covers approximately 5,700 square kilometers[10] - The Groundrush gold deposit within the CTPJV produced over 600,000 ounces of gold between 2001 and 2005 at 4 g/t Au[24,36] - The CTPJV includes a non-operating 1.2 Mtpa Carbon-in-Leach processing plant[24] Mount Gibson Iron (MGX) - MGX has substantial cash and investment reserves of $460 million as of March 31, 2025[16] - MGX has shipped over 40 million tonnes of iron ore since 2007 from Koolan Island[16] - MGX's Koolan Island mine is in its final 12-18 months of mine life[16] Valuation and Comparables - The acquisition multiple is $61/oz based on JORC 2012 Mineral Resource or $38/oz including historical (JORC 2004) estimates[29] - The average comparable transaction multiple is $174/oz[29]

Financial Performance - J.B. Hunt's Q1 2025 revenue was $2.92 billion, a 1% decrease compared to Q1 2024 [10] - Excluding fuel surcharge, Q1 2025 revenue was $2.56 billion, a 0.3% increase [10] - Q1 2025 operating income was $178.7 million, down 8% year-over-year [10] - Diluted EPS for Q1 2025 was $1.17, a 4% decrease from $1.22 in Q1 2024 [10] Segment Performance - Intermodal (JBI) revenue increased by 5% to $1.47 billion, but operating income decreased by 7% to $94.4 million [10] - Dedicated Contract Services (DCS) revenue decreased by 4% to $822 million, and operating income decreased by 14% to $80.3 million [10] - Integrated Capacity Solutions (ICS) revenue decreased by 6% to $268 million, but operating loss improved to $(2.7) million compared to $(17.5) million in Q1 2024 [10] - Final Mile Services (FMS) revenue decreased by 12% to $201 million, and operating income decreased significantly by 69% to $4.7 million [11] - Truckload (JBT) revenue decreased by 7% to $167 million, but operating income increased by 66% to $2.0 million [11] Revenue Mix - Intermodal (JBI) accounted for 50% of the company's revenue [6] - Dedicated Contract Services (DCS) accounted for 28% of the company's revenue [6] - Integrated Capacity Solutions (ICS) accounted for 9% of the company's revenue [6]

Financial Performance - FY2026 Q1 - Sales reached $154 million, with a gross profit of $4718 thousand and a gross margin of 306%[10] - Adjusted EBITDA was $2963 thousand, representing 192% of sales[10] - The company reported $656 million in cash and marketable securities[62] Key Agreements and Business Updates - Park entered into a Business Partner Agreement with ArianeGroup, selling $11 million of C2B fabric and $480 thousand of ablative materials manufactured with C2B fabric in FY2026 Q1[13] - A new agreement with ArianeGroup involves Park advancing €4587 million against future C2B fabric purchases, with the first installment of €1376 million paid in FY2026 Q1[54] - Lightning Strike Protection materials were certified on the GE Aerospace Passport 20 Engine, expecting approximately $500 thousand per year in revenues[56] GE Aerospace Programs - FY2026 Q1 sales for GE Aerospace programs were $62 million[45] - The company forecasts GE Aerospace programs sales to be between $67 million and $72 million for FY2026 Q2 and between $280 million and $320 million for the total FY2026[47] - CFM LEAP-1A engine had a 652% market share of firm engine orders for the A320neo Family of Aircraft as of March 31, 2025[34] Share Repurchase Program - During FY2026 Q1, Park purchased 166955 shares of its common stock at an average price of $1297 per share, totaling $2165453[59] - As of the report, the company has purchased a total of 718234 shares at an average price of $1294 per share, costing $9296401[59] Future Expansion - The company is planning a major new expansion of its manufacturing facilities, with a preliminary estimated capital budget of $35 million +/- $5 million[84]